학술논문

Saccharomyces: A Friend or Foe in ICU (A Case Report with Solution).
Document Type
Article
Source
Indian Journal of Critical Care Medicine. Sep2019, Vol. 23 Issue 9, p430-431. 2p. 2 Black and White Photographs.
Subject
*DIAGNOSIS of diabetes
*DIARRHEA prevention
*AMPHOTERICIN B
*CRITICALLY ill
*INTENSIVE care units
*PATIENTS
*RISK assessment
*SACCHAROMYCES
*TERMINATION of treatment
*PROBIOTICS
*TREATMENT effectiveness
*CENTRAL venous catheterization
*FUNGEMIA
*DISEASE risk factors
*OLD age
Language
ISSN
0972-5229
Abstract
Saccharomyces cerevisiae or boulardii, also known as baker's yeast or brewer's yeast, is normally a nonpathogenic microbe. It is commonly used as a probiotic to prevent antibiotic-associated diarrhea. We present a case of a 77-year-old woman with uncontrolled diabetes who developed Saccharomyces fungemia with use of Saccharomyces containing probiotic after 5 days of treatment. The probiotic was immediately discontinued. The indwelling central line was removed, she was started on amphotericin B and the fungemia resolved. This case report highlights this peculiar complication of probiotic use. We also find it important to increase the awareness amongst the healthcare providers about this likely risk while prescribing probiotics, especially for critically ill patients. [ABSTRACT FROM AUTHOR]